beta
PYXS
Pyxis Oncology Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment.
Market Cap: 278 Million
Primary Exchange: NASDAQ
Website: pyxisoncology.com
Shares Outstanding: 44.3 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.3986431098727796
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ethical Flags
Longest drawdown: 227 trading days
From: 2023-03-29 To: 2024-02-09
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|